Bloomberg News

Donation of $1.6 Million Gets Your Name on Cancer Drug, FT Says

September 01, 2012

Researchers at Uppsala University in Sweden are offering to name an experimental cancer drug after anyone who donates 1 million pounds ($1.6 million) to help fund its development, the Financial Times said.

Academics at the Swedish college are trying to raise 2 million pounds to pay for a clinical trial in as many as 20 people for the potential treatment of neuroendocrine cancer, the newspaper said, citing comments from the university.

Steve Jobs, Apple Inc.’s late co-founder, died of respiratory arrest caused by a pancreatic neuroendocrine tumor.

To contact the reporter on this story: Chris Spillane in London cspillane3@bloomberg.net.

To contact the editor responsible for this story: Andrew Blackman at ablackman@bloomberg.net.


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus